According to Biolase 's latest financial reports the company's current EPS (TTM) is -โน22,822. In 2022 the company made an earnings per share (EPS) of -โน35,404 a decrease over its 2021 EPS that were of -โน23,042.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน21,766 | -38.52% |
2022 | -โน35,404 | 53.65% |
2021 | -โน23,042 | -81.87% |
2020 | -โน1,27,064 | -25.32% |
2019 | -โน1,70,136 | -24.76% |
2018 | -โน2,26,131 | -26.06% |
2017 | -โน3,05,815 | 4.33% |
2016 | -โน2,93,132 | -14.71% |
2015 | -โน3,43,672 | -26.09% |
2014 | -โน4,64,968 | 35.41% |
2013 | -โน3,43,371 | 244.31% |
2012 | -โน99,727 | -38.05% |
2011 | -โน1,60,992 | -64.8% |
2010 | -โน4,57,327 | 347.66% |
2009 | -โน1,02,159 | -71.05% |
2008 | -โน3,52,914 | 22.58% |
2007 | -โน2,87,904 | 55% |
2006 | -โน1,85,744 | -74.03% |
2005 | -โน7,15,116 | -22.22% |
2004 | -โน9,19,435 | -208.79% |
2003 | โน8,45,137 | 1720% |
2002 | โน46,436 | -171.43% |
2001 | -โน65,011 | -65% |
2000 | -โน1,85,744 | -28.57% |
1999 | -โน2,60,042 | -56.92% |
1998 | -โน6,03,669 | 209.52% |
1997 | -โน1,95,032 | 5% |
1996 | -โน1,85,744 |